Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Sanofi’s Earnings Outlook

By Benzinga Insights
Today, 11:38 PM
Sanofi (NASDAQ:SNY) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that Sanofi will report an earnings per share (EPS) of $1.33.

SNY

Read More
3 minute read

US Stock Futures Lower Following Friday’s Rally; Tesla In Focus

By Lisa Levin
Today, 11:38 PM
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Monday after recording sharp gains in the previous session. The Dow Jones jumped by around 750 points on Friday. All the three major indices recorded their best week since June, with the S&P 500 and Dow adding 4.7% and 4.9%, respectively last week.

AVEO

Read More
2 minute read

Regeneron and Sanofi Announced Dupixent Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis in Children 1 to 11

By Charles Gross
Today, 11:38 PM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented late-breaking positive results from a Phase 3 trial evaluating the investigational use of Dupixent® (dupilumab) in children aged 1 to 11 years with active eosinophilic esophagitis (EoE).

REGN